Qingdao Vland Biotech Co Ltd Strategic Asset Allocation Index
Qingdao Vland Biotech Co Ltd strategic asset allocation index. Qingdao Vland Biotech Co Ltd (603739) has a Strategic Asset Allocation Index of 76.4% as of June 2023. Strategic assets (PP&E of CN¥1.33 Billion plus long-term investments of CN¥-) total CN¥1.33 Billion, measured against net assets of CN¥1.75 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Qingdao Vland Biotech Co Ltd (603739) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Qingdao Vland Biotech Co Ltd (2015–2022)
Strategic asset allocation index of Qingdao Vland Biotech Co Ltd from 2015 to 2022. This chart shows how Qingdao Vland Biotech Co Ltd's Strategic Asset Allocation Index has evolved across 8 annual periods from 2015 to 2022. As of June 2023, the index stands at 76.4%, representing strategic assets of CN¥1.33 Billion against net assets of CN¥1.75 Billion CNY. Check 603739 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Qingdao Vland Biotech Co Ltd Strategic Asset Allocation Index by Year (2015–2022)
Qingdao Vland Biotech Co Ltd strategic asset allocation index by year from 2015 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Qingdao Vland Biotech Co Ltd from 2015 to 2022, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Qingdao Vland Biotech Co Ltd market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 72.7% | CN¥1.26 Billion | CN¥1.26 Billion | CN¥- | CN¥1.73 Billion | ▲ +22.6 pp |
| 2021 | 50.0% | CN¥843.51 Million | CN¥843.51 Million | CN¥- | CN¥1.69 Billion | ▲ +5.1 pp |
| 2020 | 44.9% | CN¥501.01 Million | CN¥501.01 Million | CN¥- | CN¥1.12 Billion | ▲ +7.0 pp |
| 2019 | 37.9% | CN¥391.00 Million | CN¥391.00 Million | CN¥- | CN¥1.03 Billion | ▼ -20.3 pp |
| 2018 | 58.2% | CN¥367.55 Million | CN¥367.55 Million | CN¥- | CN¥631.38 Million | ▲ +2.8 pp |
| 2017 | 55.4% | CN¥328.35 Million | CN¥328.35 Million | CN¥- | CN¥592.53 Million | ▼ -0.4 pp |
| 2016 | 55.8% | CN¥311.39 Million | CN¥311.39 Million | CN¥- | CN¥557.97 Million | ▼ -4.7 pp |
| 2015 | 60.5% | CN¥314.34 Million | CN¥314.34 Million | CN¥- | CN¥519.36 Million | — |